Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-701114
  • Global Cardiology Surgical & Interventional Cardiology Devices Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • Publish: February 2016 | Report Code: HME-701114

The global cardiology surgical & interventional cardiology devices market is expected to grow at the CAGR of 8%, and will contributes $83128.34 billion till 2022. The major rise in the global cardiology surgical & interventional cardiology devices market is due to the increased prevalence of life style oriented diseases among the aging population. Cardiovascular diseases (CVD) is one of the most leading cause of death in China. Cardiovascular disease is increasing in China because of urbanization, change in dietary habits, lifestyle and smoking. Thus, it is estimated that 21.3 million cardiovascular diseases cases and 7.7 million deaths will be prevailing between 2010 and 2030. Thus, China’s population will be at a huge risk of heart and cardiovascular diseases.

Cardiology surgical & interventional cardiology devices has gone through various advancements but still the devices are very costly and limited in reach. Cardiology surgical & interventional cardiology devices is one of the helpful tool in minimizing the rate of invasive surgeries with a high successful results but again the  high cost to the buyers is one of the major factor restraining the growth of this market. Research centers and Hospitals are the key buyers of these devices. Thus the use of these devices are limited to the hospitals and research centers who has a lump sum capital to invest in it.

The major driver promoting the global cardiology surgical & interventional cardiology devices market is advancing technology which is of utmost importance in the healthcare industry. Presently, interventional cardiology surgeries with the use of 3D technologies is in trend. The former technology has been replaced by the upgraded & innovative technology.

Cardiology surgery and interventional surgery device market is segmented on the basis of catheters, imaging, surgeries, cardiac rhythm management and others including structural heart. CRDM (Cardiac Rhythm Disease Management) has the largest market share in terms of devices market. The market for Imaging Devices includes Still Imaging, Real time imaging, Magnetic Resonance Angiogram (MRA), Fluoroscopy and Cardiac Catheterization. Cardiac catheters have 40% market share in the overall catheters market. High growth rate in this segment can be attributed because of increasing company’s investments to develop advanced technologies & innovative products with better outcomes.

The global cardiology surgical & interventional cardiology devices market is divided into North America, Europe, Asia Pacific and Rest of the World. Among all, North America is the leader of the market having 46%of market shares, followed by Europe. North America is dominating country due to high prevalence of cardiovascular diseases & various technological advancements. Europe is the second major shareholder with 27% of market share in global cardiology surgical & interventional cardiology devices market. Asia pacific is the fastest growing market in this field due to increasing population & rapid development process. India & China are the major contributors in APAC region & are expected to fuel this market further.

Boston Scientific Corporation, C.R. Bard, Medtronic, Abbot Laboratories, St. Jude Medical, Cook Medical are the major key players of cardiology surgical & interventional cardiology devices market. Acquisitions & product launch with technological innovations are the key strategies adopted by the competitor. Such as Such as St. Jude Medical acquired Cardio MEMS in 2014.


CHAP 1.EXECUTIVE SUMMARY
 

CHAP 2.MARKET OVERVIEW
 2.1.MARKET ESTIMATION METHODOLOGY
 2.2.VALUE CHAIN ANALYSIS
 2.2.1.SUPPLIERS
 2.2.2.MANUFACTURERS
 2.2.3.DISTRIBUTORS & RETAILERS
 2.2.4.END USERS
 2.3.KEY BUYING CRITERIA
 2.3.1.QUALITY
 2.3.2.PRICE
 2.3.3.AVAILABILITY
 2.3.4.SUCCESS RATE
 2.4.KEY STRATEGIES
 2.4.1.INNOVATION IS THE KEY INDUSTRY STRATEGY TO OVERCOME COMPETITION
 2.5.PARTNERSHIPS, ACQUISITIONS AND MERGERS
 2.6.PRODUCT LAUNCH- A MAKE OR BREAK MARKETING STRATEGY
 

CHAP 3.MARKET DETERMINANTS
 3.1.DRIVERS
 3.1.1.GLOBAL INCREASE IN LIFE STYLE ORIENTED DISEASES & FATALITIES
 3.1.2.MEDICAL TOURISM
 3.1.3.MEDICAL TOURISM ORGANIZATIONS
 3.1.4.GLOBAL INCREASE IN HEALTHCARE SPENDING
 3.1.5.INCREASING AWARENESS OF HEALTHY LIFESTYLE TO DRIVE THE MARKET
 3.2.RESTRAINTS
 3.2.1.HIGH COST OF SURGERIES
 3.2.2.STRINGENT GOVERNMENT POLICIES AFFECT CARDIOLOGY MARKET GROWTH
 3.3.OPPORTUNITIES
 3.3.1.RESEARCH AND DEVELOPMENT TO EXPLORE HEALTHCARE ROBOTICS
 3.3.2.TECHNOLOGICAL ADVANCEMENTS IN SURGERIES
 3.3.3.US FDA APPROVED MEDICAL DEVICES
 3.4.CHALLENGES
 3.4.1.HIGH COST AND ADOPTION ISSUES OF MEDICAL DEVICES FOR HOSPITALS AND CLINICS
 3.4.2.RELIABILITY ISSUES
 

CHAP 4.MARKET SEGMENTATION
 4.1.CARDIAC RHYTHM MANAGEMENT
 4.1.1.CARDIAC RHYTHM MANAGEMENT DEVICES
 4.1.2.ICD: CARDIOVERTER/DEFIBRILLATORS (ICD'S)
 4.1.3.ATRIAL FIBRILLATION
 4.1.3.1.TREATMENT OPTIONS FOR ATRIAL FIBRILLATION
 4.1.3.2.COX-MAZE OPEN HEART PROCEDURE
 4.1.3.3.CATHETER-BASED CARDIAC ABLATION PROCEDURE
 4.2.SURGERY
 4.2.1.CORONARY ARTERIES BYPASS GRAFTING (CABG)
 4.2.2.ANGIOPLASTY
 4.2.3.TRANSMYOCARDIAL LASER REVASCULARIZATION (TMR)
 4.2.4.HEART VALVE REPAIR/REPLACEMENT
 4.2.5.ARRHYTHMIA TREATMENT
 4.2.6.ANEURYSM REPAIR
 4.2.7.HEART TRANSPLANT
 4.2.7.1.SURGERY TO PLACE VENTRICULAR ASSIST DEVICES OR TOTAL ARTIFICIAL HEARTS
 4.2.8.OPEN HEART SURGERY
 4.2.9.TYPES OF OPEN HEART SURGERY
 4.2.10.OFF PUMP HEART SURGERY
 4.2.11.MINIMALLY INVASIVE SURGERIES
 4.3.IMAGING DEVICES
 4.3.1.STILL IMAGING
 4.3.2.REAL TIME IMAGING
 4.3.3.MAGNETIC RESONANCE ANGIOGRAM (MRA)
 4.3.4.FLUOROSCOPY
 4.3.5.ECHOCARDIOGRAPHY
 4.4.CARDIAC CATHETERIZATION
 
CHAP 5.GEOGRAPHICAL ANALYSIS
 5.1.NORTH AMERICA
 5.1.1.UNITED STATES (U.S.)
 5.1.1.1.US FDA IS VIGILANT OVER INTERVENTIONAL CARDIOLOGY DEVICE MARKET
 5.1.2.CANADA
 5.1.2.1.CVD AND OTHER HEART DISEASES ARE THE LEADING CAUSE OF MORTALITY IN CANADA
 5.1.2.2.REGULATIONS IN CANADA
 5.2.EUROPE
 5.2.1.UNITED KINGDOM (UK)
 5.2.2.FRANCE
 5.2.3.GERMANY
 5.2.4.ITALY
 5.2.5.SPAIN
 5.3.ASIA PACIFIC
 5.3.1.INDIA
 5.3.2.CHINA
 5.3.2.1.DISEASES PREVALENT IN CHINA
 5.3.3.JAPAN
 5.3.4.KOREA
 5.3.5.TAIWAN
 5.4.REST OF THE WORLD
 5.4.1.BRAZIL
 5.4.2.MEXICO
 5.4.3.SOUTH AFRICA
 

CHAP 6.CORPORATE PROFILE
 6.1.BOSTON SCIENTIFIC CORPORATION
 6.1.1.OVERVIEW
 6.1.2.BOSTON SCIENTIFIC CORPORATION PRODUCTS PORTFOLIO IN CARDIAC
 6.1.3.SCOT ANALYSIS
 6.2.C.R. BARD
 6.2.1.OVERVIEW
 6.2.2.BARD PRODUCT PORTFOLIO IN CARDIAC
 6.2.3.SCOT ANALYSIS
 6.3.MEDTRONIC
 6.3.1.OVERVIEW
 6.3.2.MEDTRONIC PRODUCT PORTFOLIO IN CARDIAC
 6.3.3.STRATEGIC MOVES
 6.3.4.SCOT ANALYSIS
 6.4.ABBOT LABORATORIES
 6.4.1.OVERVIEW
 6.4.2.ABBOTT LABORATORIES PORTFOLIO IN CARDIAC
 6.4.3.SCOT ANALYSIS
 6.5.ST. JUDE MEDICAL
 6.5.1.OVERVIEW
 6.5.2.ST. JUDE MEDICAL PRODUCTS PORTFOLIO IN CARDIAC
 6.5.3.SCOT ANALYSIS
 6.6.COOK MEDICAL
 6.6.1.OVERVIEW
 6.6.2.COOK MEDICAL PRODUCTS PORTFOLIO IN CARDIAC:
 6.6.3.STRATEGIC MOVES
 6.6.4.SCOT ANALYSIS
 6.7.BIOSENSE WEBSTER
 6.7.1.OVERVIEW
 6.7.2.BIOSENSE WEBSTER PRODUCTS PORTFOLIO IN CARDIAC
 6.7.3.SCOT ANALYSIS
 6.8.EDWARDS LIFESCIENCE
 6.8.1.OVERVIEW
 6.8.2.EDWARDS LIFESCIENCES PRODUCTS PORTFOLIO IN CARDIAC
 6.8.3.STRATEGIC MOVES
 6.8.4.SCOT ANALYSIS
 6.9.TOSHIBA MEDICAL SYSTEMS
 6.9.1.OVERVIEW
 6.9.2.TOSHIBA MEDICAL SYSTEM PRODUCTS PORTFOLIO IN CARDIAC
 6.9.3.SCOT ANALYSIS
 6.10.LOMBARD MEDICAL
 6.10.1.OVERVIEW
 6.10.2.LOMBARD MEDICAL PRODUCTS PORTFOLIO IN CARDIAC
 6.10.3.SCOT ANALYSIS
 6.11.ATRICURE INC
 6.11.1.OVERVIEW
 6.11.2.ATRICURE PRODUCTS PORTFOLIO IN CARDIAC
 6.11.3.SCOT ANALYSIS
 6.12.ATRIUM MEDICAL CORPORATION
 6.12.1.OVERVIEW
 6.12.2.ATRIUM MEDICAL PRODUCTS PORTFOLIO IN CARDIAC
 6.12.3.SCOT ANALYSIS
 6.13.HANSEN MEDICAL
 6.13.1.OVERVIEW
 6.13.2.HANSEN MEDICAL PRODUCT PORTFOLIO
 6.13.3.SCOT ANALYSIS
 6.14.GE HEALTHCARE
 6.14.1.OVERVIEW
 6.14.2.GE HEALTHCARE PRODUCT PORTFOLIO
 6.14.3.STRATEGIC MOVES
 6.14.4.SCOT ANALYSIS
 6.15.PHILIPS HEALTHCARE
 6.15.1.OVERVIEW
 6.15.2.PHILLIPS HEALTHCARE PRODUCTS PORTFOLIO IN CARDIAC
 6.15.3.STRATEGIC MOVES (2013-14)
 6.15.4.SCOT ANALYSIS
 6.16.SMITH MEDICAL
 6.16.1.OVERVIEW:134
 6.16.2.SMITHS MEDICAL PRODUCTS PORTFOLIO IN CARDIAC
 6.16.3.SCOT ANALYSIS
 6.17.BERLIN HEART
 6.17.1.OVERVIEW
 6.17.2.BERLIN HEART PRODUCT PORTFOLIO IN CARDIAC
 6.17.3.STRATEGIC MOVES (2013-2014)
 6.17.4.SCOT ANALYSIS
 6.18.CAMBRIDGE HEART, INC.
 6.18.1.OVERVIEW
 6.18.2.CAMBRIDGE HEART PRODUCT PORTFOLIO IN CARDIAC
 6.18.3.SCOT ANALYSIS
 6.19.JOHNSON & JOHNSON
 6.19.1.OVERVIEW
 6.19.2.SCOT ANALYSIS

LIST OF TABLES

 

TABLE  1 GLOBAL CARDIOLOGY SURGICAL DEVICES MARKET BY SEGMENTS 2014-2022 ($ MILLION) 
TABLE  2 FACT SHEET OF CVD FATALITIES
TABLE  3 PRICE DIFFERENCE IN INDIA AND US FOR CARDIAC RELATED SURGERIES
TABLE  6 USFDA APPROVALS IN 2014
TABLE  7 GLOBAL CRDM MARKET BY REGIONS 2014-2022 ($ MILLION) 
TABLE  8 GLOBAL CRDM MARKET BY DEVICES 2014-2022 ($ MILLION) 
TABLE  9 GLOBAL DEFIBRILLATION SYSTEMS MARKET, BY REGIONS 2014-2022 ($ MILLION) 
TABLE  10 GLOBAL ATRIAL FIBRILLATION SYSTEMS MARKET, BY REGIONS 2014-2022 ($ MILLION) 
TABLE  11 GLOBAL CORONARY SURGERY MARKET, BY REGIONS 2014-2022 ($ MILLION) 
TABLE  12 GLOBAL CARDIAC SURGERY MARKET BY REGIONS 2014-2022 ($ MILLION) 
TABLE  13 GLOBAL TRANSMYOCARDIAL LASER REVASCULARIZATION (TMR) MARKET, BY REGIONS, 2013-2021
TABLE  14 GLOBAL HEART VALVE REPLACEMENT MARKET BY REGIONS 2014-2022 ($ MILLION) 
TABLE  15 GLOBAL HEART TRANSPLANT SURGERY MARKET, BY REGIONS 2014-2022 ($ MILLION) 
TABLE  16 GLOBAL CARDIAC IMAGING MARKET, BY REGIONS, 2013-2021, (IN $ MILLION)
TABLE  17 GLOBAL CARDIAC STENTS MARKET, BY REGIONS 2014-2022 ($ MILLION) 
TABLE  18 GLOBAL CARDIAC CATHETERS MARKET, BY REGIONS 2014-2022 ($ MILLION) 
TABLE  19 GLOBAL CARDIOLOGY SURGERY MARKET, BY REGIONS 2014-2022 ($ MILLION) 
TABLE  20 NORTH AMERICA CARDIOLOGY SURGICAL MARKET, BY REGIONS 2014-2022 ($ MILLION) 
TABLE  21 EUROPE CARDIOLOGY SURGICAL MARKET BY REGIONS 2014-2022 ($ MILLION) 
TABLE  22 FATALITY IN EUROPE IN 2014
TABLE  23 CVD STATISTICS OF THE UK IN 2014
TABLE  24 NUMBER OF CARDIOLOGISTS IN SPAIN
TABLE  25 ASIA PACIFIC CARDIOLOGY SURGICAL MARKET BY REGIONS 2014-2022 ($ MILLION) 
TABLE  27 ROW CARDIOLOGY SURGICAL MARKET BY REGIONS 2014-2022 ($ MILLION) 

LIST OF FIGURES
 

FIGURE  6 UNITED STATES CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION) 
FIGURE  7 CVD PREVALENCE IN CANADA,2013
FIGURE  8 CANADA CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION) 
FIGURE  9  MEN VS WOMEN FATALITY RATES IN EUROPE 2014
FIGURE  10 UNITED KINGDOM CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION) 
FIGURE  11 FRANCE CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION) 
FIGURE  12 GERMANY CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION) 
FIGURE  13 ITALY CARDIOLOGY SURGERY MARKET 2014-2022 ($ MILLION) 
FIGURE  14 INDIA CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION) 
FIGURE  15 CHINA CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION) 
FIGURE  16 JAPAN CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION) 
FIGURE  17 SOUTH KOREA CARDIOLOGY SURGICAL MARKET 2014-2022 ($ MILLION) 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample/TOC

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8966901752

Email: sales@occamsresearch.com

 

 

Go To Top
viewthroughconversion